VKH
CSBR icon

Virtu KCG Holdings’s Champions Oncology CSBR Stock Holding History

Virtu KCG Holdings’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,270
Closed -$39K – 3203
2016
Q4 		$39K Sell
15,270
-18,263
-54% -$35.6K ﹤0.01% 3139
2016
Q3 		$56K Buy
+33,533
New +$62.4K ﹤0.01% 2763

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtu KCG Holdings's CSBR Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Champions Oncology (CSBR) in Q1 2017, closing a stake of 15,270 shares — an estimated $39K sold.

Virtu KCG Holdings first reported a position in CSBR in Q3 2016 and held it in 2 quarters. The position peaked at $56K in Q3 2016. 16 funds tracked by Wall St. Rank hold CSBR as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Champions Oncology position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 15,270 Champions Oncology shares in Q1 2017, an estimated $39K.
  • Virtu KCG Holdings first reported a position in Champions Oncology in Q3 2016 and held it in 2 quarters.
  • Virtu KCG Holdings's Champions Oncology position peaked at $56K in Q3 2016.
  • 16 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.